iSonea products recognised at CES
iSonea (ASX:ISN) has revealed that its asthma monitoring technology was selected to receive a digital technology award at the Consumer Electronics Show, held in Las Vegas in early January.
The company has been given a Tech Podcast Network Innovator Pick Award for its AirSonea wheeze monitoring device.
AirSonea launched in Australia in September last year. The product also has CE Mark approval in Europe, and iSonea is aiming for a US launch this year.
The award also recognises iSonea’s AsthmaSense Prime, the smartphone app used to keep tabs on asthma symptoms.
AsthmaSense Prime uses symptoms, triggers, environmental factors and medication usage statistics to inform patients about changing asthma risks.
iSonea last year added cloud capabilities to its AsthmaSense symptom monitoring system and received a Frost & Sullivan Innovation Award for its efforts.
iSonea (ASX:ISN) shares were trading 4.11% higher at $0.38 as of around 1 pm on Thursday.
Targeting the stress system reduces Parkinson's tremors
The commonly used Parkinson's drug levodopa usually helps with tremors, but it tends to be...
DDX53 gene linked to autism spectrum disorder
While DDX53, located on the X chromosome, is known to play a role in brain development...
ADHD drug shows promise for treating meth addiction
A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be...
